Current Neuropharmacology
Title:Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders)
Volume: 13 Issue: 5
Author(s): Andre F. Carvalho and Roger S. McIntyre
Affiliation:
Export Options
About this article
Cite this article as:
Carvalho F. Andre and McIntyre S. Roger, Editorial (Thematic Issue: Translational Perspectives in Treatment-Resistant Mood Disorders), Current Neuropharmacology 2015; 13 (5) . https://dx.doi.org/10.2174/1570159X1305151013195022
DOI https://dx.doi.org/10.2174/1570159X1305151013195022 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
33
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry Side Effects of Atypical Antipsychotic Drugs
Current Pharmaceutical Design The Role of Natural Killer T Cells in Atherosclerosis
Current Immunology Reviews (Discontinued) An Evaluation of MSDC-0160, A Prototype mTOT Modulating Insulin Sensitizer, in Patients with Mild Alzheimer's Disease
Current Alzheimer Research Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies
Current Pharmaceutical Design Non-Steroidal Anti-Inflammatory Drugs used as a Treatment Modality in Subarachnoid Hemorrhage
Current Drug Safety The Development and Mechanism of Crude Oil Pour Point Depressant: A Mini-Review
Recent Innovations in Chemical Engineering Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease
Current Alzheimer Research Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Transthyretin Decrease in Plasma of MCI and AD Patients: Investigation of Mechanisms for Disease Modulation
Current Alzheimer Research Metabotropic Glutamate Receptors 7 within the Nucleus Accumbens are Involved in Relief Learning in Rats
Current Neuropharmacology Implementation of a Biocircuit Implants for Neurotransmitter Release During Neuro-Stimulation
Current Neurovascular Research Traumatic Brain Injury as a Risk Factor for Alzheimer’s Disease: Is Inflammatory Signaling a Key Player?
Current Alzheimer Research Cardiovascular Disease: What's All the AGE/RAGE About?
Cardiovascular & Hematological Disorders-Drug Targets Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic Pain
Current Drug Targets - CNS & Neurological Disorders Ruthenium Antimetastatic Agents
Current Topics in Medicinal Chemistry Part-Time α-Secretases: The Functional Biology of ADAM 9, 10 and 17
Current Alzheimer Research Current Clinical Applications of Botulinum Toxin
Current Pharmaceutical Design Adjudin - A Male Contraceptive with Other Biological Activities
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Plants Indicated by Brazilian Indians for Disturbances of the Central Nervous System: A Bibliographical Survey
Central Nervous System Agents in Medicinal Chemistry